EGF and cancer: JWG-071 potently inhibited EGF-induced ERK5 phosphorylation in the three cancer cell lines tested (active ERK5 auto-phosphorylates, resulting in a slower migrating band), without affecting EGF-induced ERK1/2 phosphorylation (Fig. 1D).